Welcome to LookChem.com Sign In|Join Free
  • or
3-(PYRIMIDIN-2-YL)BENZOIC ACID, with the molecular formula C12H9N3O2, is a benzoic acid derivative featuring a pyrimidine ring. This chemical compound has garnered attention for its potential pharmacological and biological properties, particularly as an inhibitor of the enzyme N-myristoyltransferase. This enzyme plays a role in the regulation of protein function and has been linked to various diseases, including cancer. 3-(PYRIMIDIN-2-YL)BENZOIC ACID's unique structural features and potential applications position it as a promising candidate in the fields of medicinal chemistry and drug development. However, further research is essential to elucidate its mechanism of action and explore its therapeutic potential.

579476-26-9

Post Buying Request

579476-26-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

579476-26-9 Usage

Uses

Used in Pharmaceutical Industry:
3-(PYRIMIDIN-2-YL)BENZOIC ACID is used as a pharmacological agent for its potential role in inhibiting the enzyme N-myristoyltransferase, which is involved in the regulation of protein function and has been implicated in cancer and other diseases. Its ability to target this enzyme makes it a promising candidate for the development of novel therapeutics to treat these conditions.
Used in Medicinal Chemistry Research:
3-(PYRIMIDIN-2-YL)BENZOIC ACID is utilized as a chemical probe in medicinal chemistry research to investigate its mechanism of action and explore its potential therapeutic uses. Its unique structural features and biological properties make it an interesting compound for studying enzyme inhibition and the development of new drugs targeting N-myristoyltransferase.
Used in Drug Development:
3-(PYRIMIDIN-2-YL)BENZOIC ACID is employed as a lead compound in drug development efforts, with the aim of designing and synthesizing new molecules with improved potency, selectivity, and pharmacokinetic properties. Its potential as an inhibitor of N-myristoyltransferase and its involvement in the regulation of protein function make it a valuable starting point for the development of innovative therapeutic agents to treat cancer and other diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 579476-26-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,9,4,7 and 6 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 579476-26:
(8*5)+(7*7)+(6*9)+(5*4)+(4*7)+(3*6)+(2*2)+(1*6)=219
219 % 10 = 9
So 579476-26-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H8N2O2/c14-11(15)9-4-1-3-8(7-9)10-12-5-2-6-13-10/h1-7H,(H,14,15)

579476-26-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Pyrimidin-2-yl-benzoic acid

1.2 Other means of identification

Product number -
Other names 3-pyrimidin-2-ylbenzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:579476-26-9 SDS

579476-26-9Relevant academic research and scientific papers

Discovery of acylsulfonohydrazide-derived inhibitors of the lysine acetyltransferase, kat6a, as potent senescence-inducing anti-cancer agents

Priebbenow, Daniel L.,Leaver, David J.,Nguyen, Nghi,Cleary, Benjamin,Lagiakos, H. Rachel,Sanchez, Julie,Xue, Lian,Huang, Fei,Sun, Yuxin,Mujumdar, Prashant,Mudududdla, Ramesh,Varghese, Swapna,Teguh, Silvia,Charman, Susan A.,White, Karen L.,Shackleford, David M.,Katneni, Kasiram,Cuellar, Matthew,Strasser, Jessica M.,Dahlin, Jayme L.,Walters, Michael A.,Street, Ian P.,Monahan, Brendon J.,Jarman, Kate E.,Jousset Sabroux, Helene,Falk, Hendrik,Chung, Matthew C.,Hermans, Stefan J.,Downer, Natalie L.,Parker, Michael W.,Voss, Anne K.,Thomas, Tim,Baell, Jonathan B.

, p. 4655 - 4684 (2020/06/08)

A high-throughput screen designed to discover new inhibitors of histone acetyltransferase KAT6A uncovered CTX-0124143 (1), a unique aryl acylsulfonohydrazide with an IC50 of 1.0 μM. Using this acylsulfonohydrazide as a template, we herein disclose the results of our extensive structure-activity relationship investigations, which resulted in the discovery of advanced compounds such as 55 and 80. These two compounds represent significant improvements on our recently reported prototypical lead WM-8014 (3) as they are not only equivalently potent as inhibitors of KAT6A but are less lipophilic and significantly more stable to microsomal degradation. Furthermore, during this process, we discovered a distinct structural subclass that contains key 2-fluorobenzenesulfonyl and phenylpyridine motifs, culminating in the discovery of WM-1119 (4). This compound is a highly potent KAT6A inhibitor (IC50 = 6.3 nM; KD = 0.002 μM), competes with Ac-CoA by binding to the Ac-CoA binding site, and has an oral bioavailability of 56% in rats.

ARYL SULFONOHYDRAZIDES

-

Page/Page column 40; 51, (2016/12/26)

Compound of formula (I) wherein A is selected from (i), where RF1 is H or F; (ii); (iii) a N-containing C6 heteroaryl group; and B is (B), where X1 is either CRF2 or N, where RF2 is H or F; X2 is either CR3 or N, where R3 is selected from H, Me, CI, F OMe; X3 is either CH or N; X4 is either CRF3 or N, where RF3 is H or F; where only one or two of X1, X2, X3 and X4 may be N; and R4 is selected from I, optionally substituted phenyl, optionally substituted C5-6 heteroaryl; optionally substituted C1-6 aIkyI and optionally substituted C1-6 alkoxy, which are useful in the treatment of a condition ameliorated by the inhibition of MOZ.

A convenient synthesis of heteroaryl benzoic acids via Suzuki reaction

Gong, Yong,Pauls, Henry W.

, p. 829 - 831 (2007/10/03)

An one step approach to heteroaryl benzoic acids from readily accessible heteroaryl halides and carboxybenzene boronic acids is described. The Suzuki coupling is carried out in the presence of Pd(PPh3)4 and sodium carbonate in aqueous acetonitrile. The scope and limitations of the reaction are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 579476-26-9